TScan Therapeutics
TCRX
#8994
Rank
S$0.12 B
Marketcap
$2.09
Share price
0.00%
Change (1 day)
-80.00%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$3.93

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.78. In 2022 the company made an earnings per share (EPS) of -$3.60 a decrease over its 2021 EPS that were of -$2.85.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.939.28%
2022-$3.6026.25%
2021-$2.8599.58%
2020-$1.43